Sage Therapeutics, Inc. Marketable Securities (Current)
Sage Therapeutics, Inc. had Marketable Securities (Current) of $298.08 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-07-30
- 2025-06-30: Marketable Securities, Current $298.08M.
- 2025-03-31: Marketable Securities, Current $378.63M.
- 2024-12-31: Marketable Securities, Current $423.40M.
- 2024-09-30: Marketable Securities, Current $469.53M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-06-30 | $298.08M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $378.63M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $423.40M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $469.53M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $546.89M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $544.36M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $682.19M 10-K · filed 2025-02-11 |
| 2023-09-30 | $727.34M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $881.20M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $923.03M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.11B 10-K · filed 2024-02-14 |
| 2022-09-30 | $1.19B 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.31B 10-Q · filed 2022-08-02 |
| 2022-03-31 | $1.45B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.45B 10-K · filed 2023-02-16 |
| 2021-09-30 | $1.42B 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.40B 10-Q · filed 2021-08-03 |
| 2021-03-31 | $1.10B 10-Q · filed 2021-05-04 |
| 2020-12-31 | $438.47M 10-K · filed 2022-02-24 |
| 2020-09-30 | $484.27M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $498.29M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $673.31M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $881.69M 10-K · filed 2021-02-24 |
| 2019-09-30 | $863.07M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.07B 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.01B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $731.83M 10-K · filed 2020-02-27 |
| 2018-09-30 | $768.28M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $766.60M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $525.96M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $212.61M 10-K · filed 2019-02-19 |
| 2017-09-30 | $108.53M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $152.48M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $197.10M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $228.96M 10-K · filed 2018-02-22 |
| 2016-09-30 | $111.19M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $83.29M 10-Q · filed 2016-08-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-24 |